“Tectorigenin inhibits Caco-2 human colon cells via NF-κB pathway suppression”, Bangladesh J Pharmacol, vol. 10, no. 4, pp. 948–955, Nov. 2015, doi: 10.3329/bjp.v10i4.23833.